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Objective: Permeability parameters from dynamic contrast-enhanced MRI (DCE-MRI) and apparent diffusion coefficient 
(ADC) value on diffusion-weighted imaging (DWI) can be quantitative physiologic metrics for gliomas. The transfer constant 
(Ktrans) has shown efficacy in grading gliomas. Volume fraction of extravascular extracellular space (ve) has been 
underutilized to grade gliomas. The purpose of this study was to evaluate ve in its ability to grade gliomas and to assess 
the correlation with other permeability parameters and ADC values.
Materials and Methods: A total of 33 patients diagnosed with pathologically-confirmed gliomas were examined by 3 T MRI 
including DCE-MRI and ADC map. A region of interest analyses for permeability parameters from DCE-MRI and ADC were 
performed on the enhancing solid portion of the tumors. Permeability parameters form DCE-MRI and ADC between low- and 
high-grade gliomas; the diagnostic performances of presumptive metrics and correlation among those metrics were 
statistically analyzed.
Results: High-grade gliomas showed higher Ktrans (0.050 vs. 0.010 in median value, p = 0.002) and higher ve (0.170 vs. 
0.015 in median value, p = 0.001) than low-grade gliomas. Receiver operating characteristic curve analysis showed 
significance in both Ktrans and ve for glioma grading. However, there was no significant difference in diagnostic performance 
between Ktrans and ve. ADC value did not correlate with any of the permeability parameters from DCE-MRI.
Conclusion: Extravascular extracellular space (ve) appears to be comparable with transfer constant (K
trans) in differentiating 
high-grade gliomas from low-grade gliomas. ADC value does not show correlation with any permeability parameters from 
DCE-MRI.
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INTRODUCTION
Gliomas are the most common primary brain tumors. 
World Health Organization (WHO) classification of brain 
tumors is used as the primary basis to guide therapy and 
to assess overall prognosis in patients with brain tumors 
(1). Permeability parameters from dynamic contrast-
enhanced (DCE) MRI and apparent diffusion coefficient 
(ADC) are quantitative physiologic metrics for tumor 
microenvironments and are used as independent imaging 
biomarkers for tumor grading, for gauging tumor treatment 
response, and for estimating tumor prognosis (2-7). DCE-
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MRI has strong advantages in quantifying permeability 
parameters regardless of the biologic situation, method of 
image acquisition, and contrast injection with improved 
spatial resolution (8, 9). The transfer constant (Ktrans) has 
shown efficacy in the grading of gliomas (10-12). Contrary 
to transfer constant (Ktrans), volume fraction of extravascular 
extracellular space (ve) has been underused in glioma 
grading (13, 14). Extravascular extracellular space (ve) 
has been considered as an index of tumor necrosis and 
an inverse index of tumor cellularity (15). ADC negatively 
correlates with tumor cellularity (16, 17). Therefore, 
theoretically, extravascular extracellular space (ve) and 
ADC may show correlation. Comprehensive understanding 
about extravascular extracellular space (ve) in correlation 
with other permeability parameters and ADC values need 
investigation. The purpose of this study was to evaluate 
extravascular extracellular space (ve) to grade gliomas, and 
to assess the correlation among permeability parameters 
(Ktrans, ve, and vp) and ADC values.
MATERIALS AND METHODS
Patients
The institutional review board waived patient consent for 
this retrospective study. Perfusion study in brain tumors 
are already widely used in clinical field and non-invasive 
additional pulse sequence does not need informed consent 
form. Thirty-three patients (50.79 ± 18.34 year-old) who 
had been diagnosed with an intraaxial tumor between 
April 2009 and March 2010 were included in this study; all 
patients had been examined by preoperative MR imaging 
including DCE-MRI and ADC mapping. Patients had no 
history of previous surgery for brain tumor. All the tumors 
were pathologically proven as gliomas after craniotomy 
and tumor resection. The interval between preoperative 
MR imaging and surgery was less than 10 days in 30 
patients. Only 3 patients had the interval of 11 days and 
14 days between MR imaging and surgery. The gliomas were 
classified by 2007 WHO criteria. Gliomas of WHO grade 1 
and WHO grade 2 were grouped as low-grade gliomas and 
gliomas of WHO grade 3 and WHO grade 4 were grouped as 
high-grade gliomas for the purposes of analysis.
Image Acquisition
Preoperative images were taken using the 3.0-teslar 
system (Achieva, Philips, Best, the Netherlands) and 
8-channel SENSE head coil. Anatomical MR imaging for 
preoperative evaluation and ADC map were acquired. 
Diffusion weighted images were measured using the 
following parameters: field of view (FOV), 220 mm; matrix, 
112 x 112; slice thickness, 2 mm; and slice gap, 0 mm. 
ADC maps were generated from diffusion weighted images 
of b-value of 1000 s/mm2 and 0 s/mm2. Dynamic contrast-
enhanced MR images were obtained in all of the patients 
and they were all applicable to the analysis. For DCE-
MRI, precontrast 3 dimensional T1-weighted images were 
obtained with following parameters: FOV, 240 mm; matrix, 
192 x 192; slice thickness, 3 mm; slice gap, 0 mm; and flip 
angle of 5°. After precontrast scan, 60-dynamic contrast-
enhanced T1-weighted images were taken with the same MR 
parameters except for flip angle of 15° with an injection of 
Gadovist (0.1 mL/kg) at a rate of 2 mL/sec. Total scan time 
for DCE MRI was less than 7 minutes.
Data Analysis
Permeability parameters were calculated by off-line Pride 
tools provided by Philips Medical System, which is based on 
the pharmacokinetic model of Tofts (18). Post-processing 
was composed of motion correction of pixels from dynamic 
images, T1 mapping using different flip angles (5° and 15°), 
registration of pixels on T1 map, arterial input function 
estimation, and pharmacokinetic modeling. All processes 
were performed automatically by Pride tools, except for 
drawing the regions of interest (ROIs) for permeability 
parameters of the tumor and arterial input function. A 
neurologist (H.S.C.) with 5-years of experience drew the 
ROI, while blinded to the patients’ pathology results. ROIs 
were drawn at the maximal enhancing solid portion of the 
tumor on contrast-enhanced T1 weighted images, where 
the highest grade of each tumor was suspected. If there 
was no visual enhancement of the tumor, ROI was drawn 
at the center of the solid portion where the T2-signal 
abnormality was noted after careful inspection of T1- and 
T2-weighted images. The ROIs of the tumor were duplicated 
on each permeability map (Ktrans, ve, and vp) automatically 
by Pride tools. The size of the ROIs of the tumors was 51.33 
± 31.73 pixels (mean ± standard deviation), 20 pixels in 
minimum, and 137 pixels in maximum. ROIs on ADC map 
were manually drawn at the corresponding area of ROIs on 
permeability map. There was no post-processing method 
for co-registration of algorithms for permeability map and 
ADC map. ROI for arterial input function was drawn at the 
M1 segment of the middle cerebral artery, ipsilateral to the 
tumor. Mean values of permeability parameters (Ktrans, ve, 
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and vp) were calculated at the selected ROIs of gliomas. 
Mean values of ADC were measured at the corresponding 
ROI as that of permeability maps. Variables of low- and 
high-grade gliomas were not satisfactory with assumptions 
of t-test. Therefore, Mann-Whitney U test was used to 
compare permeability parameters (Ktrans, ve, and vp) and ADC 
values between low-grade gliomas (WHO grade 1 and 2) 
and high-grade gliomas (WHO grade 3 and 4). Presumptive 
variables from Mann-Whitney U test were chosen for ROC 
curve analysis to evaluate the diagnostic performance for 
differentiating high-grade gliomas from low-grade ones. 
Spearman correlation analyses were performed among 
the permeability parameters and ADC values. Statistical 
significance was set at a p-value < 0.05.
RESULTS
Thirty-three gliomas were confirmed by pathology: 
15, glioblastomas; 6, anaplastic astrocytomas; 4, 
diffuse astrocytomas; 3, mixed oligoastrocytomas; 2, 
oligodendrogliomas; 2, anaplastic oligodendrogliomas; 
and 1, pilocytic astrocytoma. According to 2007 WHO 
classification, there was one, WHO grade 1; 9, WHO grade 2; 
8, WHO grade 3; and 15, WHO grade 4 gliomas.
High-grade gliomas showed higher Ktrans (0.050 vs. 0.010 
in median value, p = 0.001) and higher ve (0.170 vs. 0.015 
in median value, p < 0.001) than low-grade gliomas (Figs. 
1, 2, Table 1). There was no statistical difference in plasma 
volume fraction (vp) between high- and low-grade gliomas 
(Table 2).
ROC curve analysis showed significant area under curve 
of transfer constant (Ktrans) and extravascular extracellular 
space (ve) for differentiating high-grade gliomas from low-
Fig. 1. Box plot of transfer constant (Ktrans) between low- and 
high-grade gliomas. Low grade refers to gliomas of grades WHO 1 
and 2; high grade refers to gliomas of grades WHO 3 and 4. WHO = 
World Health Organization
0.20
0.15
0.10
0.05
0.00
Tr
an
sf
er
 c
on
st
an
t
33
6
*
Low grade High grade
WHO classification
Fig. 2. Box plot of extravascular extracellular space (ve) 
between low- and high-grade gliomas. Low grade refers to gliomas 
of grades WHO 1 and 2; high grade refers to gliomas of grades WHO 3 
and 4. WHO = World Health Organization
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Table 1. Result from Applying Mann-Whitney U Test to 
Permeability Parameters and ADC Value between High- and 
Low-Grade Gliomas (Median, Interquartile Range)
Ktrans (min-1) ve vp
ADC 
(*10-3 mm2/s)
High-grade* 0.050, 0.08 0.170, 0.17 0.030, 0.02 0.972, 0.31
Low-grade* 0.010, 0.02 0.015, 0.07 0.030, 0.01 1.163, 0.52
P value 0.002 0.001 0.832 0.114
Note.— *High-grade refers to WHO grade 3 and 4; low-grade, WHO 
grade 1 and 2. ADC = apparent diffusion coefficient, WHO = World 
Health Organization
Table 2. Correlation Matrix for Permeability Parameters and 
ADC Value and Spearman’s Rho between Them (With p-values)
Ktrans (min-1) ve vp
ADC 
(*10-3 mm2/s)
Ktrans 1.000
0.878 
(< 0.001)**
0.341 
(0.052)
0.004 
(0.981)
ve
0.878 
(< 0.001)**
1.000
0.395 
(0.023)*
0.068 
(0.708)
vp
0.341 
(0.052)
0.395 
(0.023)*
1.000
0.027 
(0.882)
ADC
0.004 
(0.981)
0.068 
(0.708)
0.027 
(0.882)
1.000
Note.— *Correlation is significant at level of p < 0.05 (2-tailed), 
**Correlation is significant at level of p < 0.01 (2-tailed). ADC = 
apparent diffusion coefficient
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grade ones (Fig. 3). The area under curve, lower bound, and 
upper bound of 95% confidence interval was 0.833, 0.648, 
and 1.017 for transfer constant (Ktrans); 0.857, 0.719, and 
0.994 for extravascular extracellular space (ve). However, 
there was no statistical difference between diagnostic 
performance of Ktrans and ve.
Spearman correlation analysis of permeability parameters 
and ADC value showed correlation between Ktrans and ve at 
the level of p < 0.01, and correlation between ve and vp at 
the level of p < 0.05 (Fig. 4, Table 2). However, ADC values 
did not correlate with any of the permeability parameters 
(Table 2).
DISCUSSION
This study evaluated permeability parameters and ADC 
values for differentiating high- and low-grade gliomas 
with emphasis on extravascular extracellular space (ve). 
Higher transfer constant (Ktrans) and higher extravascular 
extracellular space (ve) were observed by DCE-MRI in high-
grade gliomas compared to low-grade gliomas. The finding 
of a correlation between higher Ktrans and high-grade 
gliomas was comparable with previous studies. However, 
to the best of our knowledge, there were few reports about 
correlation between extravascular extracellular space (ve) 
and glioma grade. This finding was observed in the recent 
literature (13, 14). The values of extravascular extracellular 
space (ve) were also similar to our results: mean ve, 0.20 for 
high grade glioma; and mean ve, 0.01 for low grade glioma 
(14). Increase in fractional interstitial volume in high-
grade gliomas also supports potential use of extravascular 
extracellular space in differentiating brain tumors (19). 
A longitudinal MR imaging using in-vivo glioma in mouse 
model showed progression of tumor vascularization, 
increase in permeability and extravascular extracellular 
space (ve) along with tumor growth (20). A marked increase 
in the extravascular extracellular space (ve) in the later 
growth stage of high-grade gliomas has been observed 
in this study. It is consistent with high grade glioma 
demonstrating tumor necrosis during the latter growth 
stages in humans (21). A rapid increase in the volume 
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Fig. 3. ROC curve of transfer constant (Ktrans) and extravascular 
extracellular space (ve) for differentiating high grade gliomas 
from low-grade gliomas. Dotted line is transfer constant (Ktrans); 
solid line is extravascular extracellular space (ve).
Fig. 4. Scatter plots for statistically significant variables. 
A. Transfer constant (Ktrans) vs. extravascular extracellular space (ve). B. Extravascular extracellular space (ve) vs. plasma volume fraction (vp).
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of a high-grade glioma will lead to regional hypoxia and 
necrosis, consequently resulting in release of angiogenic 
cytokines such as vascular endothelial growth factor; 
this induces increases in angiogenesis and microvascular 
leakage. Metrics such as Ktrans, ve, and vp can be changed 
coincidentally and dynamically in the growth of a glioma 
tumor (18). Our results showed positive correlations among 
Ktrans, ve, vp, and with each other. This was comparable 
with a study about enhancing fractions in glioma showing 
correlation among each of the permeability parameters (22). 
Those permeability metrics are expected to be used not 
only in differentiating high- and low-grade gliomas but also 
in monitoring response to targeted therapy and correlating 
immunohistochemical tumor markers.
Generally, high signal intensity on diffusion weighted 
image and low ADC value represents high cellularity and low 
extravascular extracellular space (ve). Therefore, ADC value 
has been considered as an inverse index of tumor cellularity 
(16, 17). Extravascular extracellular space (ve) has been 
considered an index of tumor necrosis and an inverse index 
of tumor cellularity. Therefore, theoretically, extravascular 
extracellular space (ve) and ADC should show correlation. 
However, our results showed ADC did not correlate with any 
permeability parameters. Although there have been few 
reports on this topic, no correlation between extravascular 
extracellular space (ve) and ADC has been shown (15). Our 
study included not only high grade gliomas (n = 23), but 
also low grade gliomas (n = 10), which were different from 
the previous study. A possible explanation is that ADC value 
will be affected not only by extravascular extracellular 
space but also by various physiologic parameters, such as 
tumor cellularity, capillary bed perfusion, and permeability 
(16, 17, 23, 24). Further research about those metrics of 
permeability parameters and ADC seems to be necessary.
Our study has several limitations: a retrospective 
design, a small sample size, and heterogeneity of tumor 
pathology. There were many cases of oligodendrogliomas, 
oligoastrocytomas, and anaplastic oligodendrogliomas 
different from astrocytomas in nature. Also, the size of our 
study was too small to evaluate diagnostic performance 
of permeability parameters and ADC in differentiating 
high- and low-grade gliomas. Further large scale research 
seems necessary for understanding the nature of those 
metrics in relation to the grade of gliomas. Second, 
extravascular extracellular space (ve) measured by DCE-MRI 
can be affected by the scanning time of dynamic images. 
We used the same DCE-MRI protocols for all enrolled 
patients. However, different scanning time of DCE-MRI 
may be a potential confounder. Moreover, extravascular 
extracellular space (ve) cannot be estimated in tissue where 
capillary perfusion pressure is too low for contrast media 
to extravasate. Third, because of the given heterogeneity 
of high-grade gliomas, such as necrotic change, edema, 
hemorrhage, and microvascular proliferation, the ROI-
based method used in this study has a potential weakness 
in evaluating gross characteristics of the gliomas. Voxel 
based analysis of whole tumor volume with coregistration 
technique between DCE-MRI and ADC should be considered 
in a future study. Finally, there was no post-processing 
method for coregistration of permeability maps and ADC 
map. Therefore, there is potential error in ROI measurement. 
To overcome this error, we measured mean values of 
permeability maps (Ktrans, ve, and vp) and ADC maps using 
ROI-based method instead of maximal or minimal values. 
Although correlation analyses of mean values from 
permeability maps and ADC maps may be less affected by 
misclassification than correlation analyses of maximal or 
minimal values, careful interpretation should be needed for 
this result.
Conclusion
Extravascular extracellular space (ve) was comparable 
with transfer constant (Ktrans) in differentiating high-grade 
gliomas from low-grade gliomas. ADC value did not show 
correlation with any of the permeability parameters from 
DCE-MRI. Further investigation of these metrics is needed 
at this stage.
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